ONCONOVA THERAPEUTICS
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
ONCONOVA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
1998-01-01
Address:
Newtown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.onconova.com
Total Employee:
11+
Status:
Active
Contact:
2677593681
Total Funding:
177.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Cell Reserves
Cell Reserves is a Canadian biopharmaceutical company developing a biomolecular shield for therapeutic molecules
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Kanisa Pharmaceuticals
Kanisa Pharmaceuticals is a biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Thomas J. McKearn President, Research and Development @ Onconova Therapeutics
President, Research and Development
2012-09-01
Dave Stephon Senior Vice President, Quality Management @ Onconova Therapeutics
Senior Vice President, Quality Management
Manoj Maniar Senior Vice President, Product Development @ Onconova Therapeutics
Senior Vice President, Product Development
Steven Fruchtman President and CEO @ Onconova Therapeutics
President and CEO
2019-01-01
Mark Guerin CFO @ Onconova Therapeutics
CFO
Ric Woodman Chief Medical Officer and Senior Vice President of Research and Development @ Onconova Therapeutics
Chief Medical Officer and Senior Vice President of Research and Development
E. Premkumar Reddy Board of Directors & Founded @ Onconova Therapeutics
Board of Directors & Founded
1998-01-01
Michael B. Hoffman Chairman, Board of Directors @ Onconova Therapeutics
Chairman, Board of Directors
Founder
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Onconova Therapeutics
Sio Capital Management
Sio Capital Management investment in Post-IPO Equity - Onconova Therapeutics
Official Site Inspections
http://www.onconova.com Semrush global rank: 2.52 M Semrush visits lastest month: 6.99 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Onconova Therapeutics"
Onconova Therapeutics - Crunchbase Company Profile & Funding
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a …See details»
Investor Relations | Onconova Therapeutics
Mar 26, 2025 Onconova Therapeutics. About Us; Patients; Pipeline; Clinical Trials; Partnering; Investors & Media; Contact; GET IN TOUCH. Address: 12 Penns Trail Newtown, PA 18940 …See details»
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc.
Apr 2, 2024 Management and Organization. ... M.D., President and Chief Executive Officer of Onconova and President and CSO, Oncology of the combined company, ”Trawsfynydd has a …See details»
Onconova Therapeutics, Inc. - A Phase 3 stage biopharmaceutical …
Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a …See details»
Onconova Therapeutics - Funding, Financials, Valuation & Investors
Onconova Therapeutics is registered under the ticker NASDAQ:ONTX . Their stock opened with $15.00 in its Jul 25, 2013 IPO. Onconova Therapeutics is funded by 3 investors. Lincoln Park …See details»
Onconova - Company Profile - Tracxn
Feb 8, 2025 Onconova has three product candidates in clinical trials and six active pre-clinical programs. Lead candidate is Rigosertib, which is in advanced clinical development for the …See details»
Onconova Therapeutics
Feb 25, 2025 Onconova Therapeutics was founded in 2003 to develop novel treatments for people with cancer. In 2008 the company achieved its first regulatory filing for an …See details»
Investor FAQs - Onconova Therapeutics
You may also request a copy of these filings, at no cost, by writing or telephoning us at: Onconova Therapeutics, Inc., 375 Pheasant Run, Newtown, PA 18940, (267) 759-3680. What is the …See details»
Onconova Therapeutics Overview | SignalHire Company Profile
Onconova Therapeutics is a public company that has been in the industry for 25 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of …See details»
Onconova Therapeutics, Inc. And Trawsfynydd Therapeutics, Inc.
Apr 2, 2024 Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), and Trawsfynydd Therapeutics, Inc. (“Trawsfynydd”), a privately-held biotechnology company developing next …See details»
Onconova Therapeutics - Craft
Jun 3, 2024 Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a …See details»
Onconova Therapeutics, Inc. (ONTX): history, ownership, mission, …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Onconova Therapeutics, Inc. (ONTX) Company Foundation and Early Development Onconova …See details»
Onconova Therapeutics - Contacts, Employees, Board Members
Onconova Therapeutics has 7 current employee profiles, including President, Research and Development Thomas J. McKearn. Onconova Therapeutics has 5 board members and …See details»
Onconova Therapeutics | Newtown PA - Facebook
May 7, 2024 Onconova Therapeutics, Newtown, Bucks County, Pennsylvania. 1,026 likes · 1 was here. Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage …See details»
Onconova Therapeutics 2025 Company Profile: Stock Performance ...
Onconova Therapeutics’s primary industry is Biotechnology. Is Onconova Therapeutics a private or public company? Onconova Therapeutics is a Public company. Who are Onconova …See details»
GVK Biosciences and Onconova Therapeutics Establish Novel Joint ...
Research and Development organization and Onconova Therapeutics, a U.S. based biopharmaceutical company primarily focused on discovery and development of novel small …See details»
Onconova Therapeutics Announces Poster Presentation at the …
NEWTOWN, Pa., June 05, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on …See details»
Onconova Therapeutics, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Onconova Therapeutics is a …See details»
Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of ...
NEWTOWN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on …See details»
Patient-reported outcomes from the MIRASOL trial evaluating ...
2 days ago MIRV did not seem to impair or improve patient quality of life compared with investigator's choice of chemotherapy. The similar quality-of-life outcomes in the two treatment …See details»